Nurses boost wellbeing for cancer survivors

 

Brisbane, Australia (October 14, 2011) – A one-off consultation with a nurse at the end of cancer treatment can make a difference to a patient’s ongoing physical and emotional wellbeing. The Queensland University of Technology (QUT ) School of Nursing and Midwifery has designed a program to assist cancer survivors in self-managing their health and emotional concerns.

 

Participants in this pilot program have reported a lower need for ongoing information and emotional support, compared to those who did not take part in the program.

 

"There are a range of post-treatment effects people might experience, in the short term and potentially even in the long term, including fatigue, difficulty sleeping, weight gain or weight loss, menopausal symptoms, and peripheral neuropathy – tingling and painful sensations related to changes to nerve endings," lead investigator Professor Patsy Yates said.

 

"There are also emotional effects: things like loss of confidence in your body and dealing with a changed perception of your health."

 

Professor Yates said the main aim of the QUT research, which was funded by the Federal Department of Health and Ageing, was to develop people’s skills in managing these sorts of issues themselves.

 

"Self-management is important because when you finish treatment, you do continue to be monitored – usually by your GP – but you no longer have the same regular contact with health professionals that you were having during your treatment," she said.

 

"For the purposes of this research project we delivered a training program for nurses from Toowoomba Hospital and Princess Alexandra Hospital (Brisbane) who were cancer care coordinators, to give them techniques to teach self-management skills to patients.

 

"Nurses who received that training worked with 32 patients to develop end-of-treatment care plans, in a one-off consultation. Within that care plan they focused on the concerns and effects being experienced by each patient, and developed specific strategies to deal with those.

 

"The nurses were also available for follow up phone calls, if required."

 

A further 35 patients in a comparison group didn’t receive this intervention.

 

"The main thing we found was that 64 per cent of people who received the intervention had no need for further information about how to manage the effects they were experiencing, whereas only 45 per cent in the comparison group felt they had no need for further information," Professor Yates said.

 

"There was also a lower proportion of patients from the intervention group who felt they needed emotional support from others. We found that 34 per cent of patients who received the intervention reported their need for emotional support had decreased following the intervention, while seven per cent of those in the comparison group reported an increase in their need for support.

 

"We also sent the patients‘ care plans to their GPs, who were asked to provide us with some feedback. All of the GPs who responded rated it as being very useful."

 

The QUT research team has gone on to develop an online educational program which will eventually be accessible to all nurses at www.cancerlearning.gov.au

 

 


Queensland University of Technology, Brisbane, Australia, 14.10.2011 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…